Study of TAS-102 in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies
Public ClinicalTrials.gov record NCT01607957. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Double-blind, Phase 3 Study of TAS-102 Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the efficacy and safety of TAS-102 versus placebo in patients with refractory metastatic colorectal cancer.
Study identification
- NCT ID
- NCT01607957
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 800 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 17, 2012 (Actual)
- Primary completion
- Jan 31, 2014 (Actual)
- Completion
- May 23, 2016 (Actual)
- Last update posted
- Sep 19, 2024
2012 – 2016
United States locations
- U.S. sites
- 23
- U.S. states
- 13
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Center for Cancer Care | Glendale | Arizona | 85306 | — |
| California Cancer Associates for Research and Excellence | Fresno | California | 93720 | — |
| Ronald H. Yanagihara, MD | Gilroy | California | 95020 | — |
| LAC and USC Medical Center | Los Angeles | California | 90033 | — |
| USC Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| Pacific Hematology Oncology Associates | San Francisco | California | 94115 | — |
| San Jose Medical Group | San Jose | California | 95124 | — |
| Coastal Integrative Cancer Care | San Luis Obispo | California | 93401 | — |
| Yale Cancer Center | New Haven | Connecticut | 06520 | — |
| MD Anderson Cancer Center Orlando | Orlando | Florida | 32806 | — |
| Illinois Cancer Care, P.C. | Peoria | Illinois | 61615 | — |
| Indiana University Simon Cancer Center | Indianapolis | Indiana | 46202 | — |
| Mary Bird Perkins Cancer Center | Baton Rouge | Louisiana | 70809 | — |
| Ochsner Clinic Fndtn | New Orleans | Louisiana | 70121-2429 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | — |
| St. Joseph Mercy Hospital | Ann Arbor | Michigan | 48106 | — |
| Jefferson City Medical Group | Jefferson City | Missouri | 65109-6023 | — |
| Saint Luke's Cancer Institute | Kansas City | Missouri | 64111 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| Hickman Cancer Center at Flower Hospital | Sylvania | Ohio | 43560 | — |
| Hematology/Oncology Associates of Fredericksburg | Fredericksburg | Virginia | 22408 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 92 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01607957, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 19, 2024 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01607957 live on ClinicalTrials.gov.